Diabetes Mellitus, Type I Clinical Trial
Official title:
Nocturnal Hypoglycemia Prevention Study: Effect of the Fat Content of the Bedtime Snack on Overnight Hypoglycemia
Low blood sugar at night (called nocturnal hypoglycemia), can often happen without symptoms
and can last for a long time. Doctors often suggest that patients take a bedtime snack to
try to prevent low blood sugar at night from happening, but it is not known what type of
snack is best to take. We are conducting a study to evaluate how two different types of
snacks affect how often the blood sugar is too low overnight. One snack will be a primarily
carbohydrate snack and the other will be a carbohydrate snack with fat. The snacks will be
provided by the study.
As part of the study, a continuous glucose sensor (the Freestyle Navigator) will be worn
overnight. The Freestyle Navigator was developed by Abbott Diabetes Care. This sensor uses a
glucose oxidase based electrochemical sensor, and is designed to measure blood glucose
levels in a range of 20-500 mg/dl. The sensor is inserted subcutaneously and measures
interstitial glucose. In human studies the interstitial glucose levels generally lag behind
the blood glucose by 3 to13 minutes.(27, 28)
The Freestyle Navigator, provides a glucose reading every 60 seconds (or 1440 readings a
day). Each sensor is designed to provide readings for up to 120 hours. It has alarms for
hypoglycemia and hyperglycemia and for projected high and low glucose values. The alarm set
points can be adjusted by the user. The Navigator also has a trend arrow indicating the
glucose rate of change (>-2 mg/dL/min, -2 to -1 mg/dL/min, -1 to 1 mg/dL/min, 1 to 2
mg/dl/min, and >2 mg/dl/min). Subjects can enter events, such as when they took insulin,
ate, or exercised. The sensor requires calibration values to be entered 3 times during the
first day of wear, and then 2 additional times during the 5-day wear period. The values are
entered directly into the Navigator which has a Freestyle home glucose meter built into the
unit. The Navigator has not yet been approved by the FDA. The Navigator currently under
review by the FDA will limit sensor wear to 3 days.
This study is being done to see if there is a difference in low blood sugar overnight after
having a bedtime snack made up of carbohydrate compared to a carbohydrate snack with more
fat.
There will be about 100 children in the study. The children will take part at five centers
in the United States.
When a child enters the study, the following will be done:
1. The parent and child will be asked about the child's diabetes management including the
child's overnight basal rates, correction doses, and bolus doses to cover a bedtime
snack and whether these change depending on how active the child's day was.
2. The parent and child will be taught to use the Navigator. The first sensor will be
inserted by the parent or child with guidance from the study nurse. The child will wear
this sensor for 5 days. The parent and child will not be able to see the results from
the sensor.
3. The parent and child will be instructed to test the child's blood sugar at least 4
times each day (before each meal and at bedtime) using the Freestyle home glucose meter
built into the Navigator. Additional testing will be done as needed to calibrate the
Navigator.
4. The parent and child will be given instructions on how to use the study website to
complete a questionnaire each night about the child's bedtime blood sugar reading and
how active the child's day was.
5. The parent and child will return to the clinic for a visit 4 to 30 days later. The
Navigator will be connected to a computer and the questionnaires the parent/child
completed on the DirecNet website will be reviewed.
If the child was able to wear the Navigator, complete the blood sugar testing, and complete
the questionnaire each night on the DirecNet website, the child will continue in the study.
1. The child will be asked to wear 3 sensors to get at least 12 nights of readings during
a three week period.
2. The parent and child will be taught to use the accelerometer. This is a device that
measures the amount of movement your child has. It is about 1.75 inches long and about
1.75 inches wide and is strapped to the skin either around the waist, the wrist or the
ankle.
3. The parent and child will be given instructions on how to use the study website to
complete a questionnaire to obtain the type of bedtime snack to have. The amount of
snack and the insulin dose to cover the bedtime snack will be based on the child's
usual diabetes management. On six of the nights the child will be asked to eat the
primarily carbohydrate snack and on the other six nights, the child will be asked to
eat the carbohydrate plus fat snack. The order of the snacks will be chosen at random
by the computer. If a drink is needed, the child will be asked to drink only water with
the bedtime snack.
4. The child will be asked to do the following before returning for a clinic visit about 3
weeks later:
- Check the blood sugar at least 4 times each day using the Freestyle home glucose
meter built into the Navigator and as needed to calibrate the device.
- Wear three Navigator sensors to get a total of at least 12 nights of blood sugar
readings
- Enter a meal marker event into the Navigator each time the child has a meal or
snack
- Enter an exercise marker event into the Navigator each time the child exercises
- Wear an accelerometer at all times (day and night) when the Navigator is worn
- Complete a short questionnaire on the study website each of the 12 nights when the
Navigator and accelerometer are worn to find out the type of bedtime snack to
have.
Follow-up Visit After using the Navigator at home for 12 nights, the child will return to
the clinic for the follow-up visit.
1. The Navigator and the accelerometer will be connected to a computer so that the data
can be saved.
- If the child does not have at least 12 nights with at least 5 hours of Navigator
data in the monitor and a completed website questionnaire, he or she will be given
another sensor and additional snacks and asked to come back in another week.
2. Once the child has at least 12 nights with at least 5 hours of Navigator data and a
completed website questionnaire, the information from the device will be reviewed with
the parent and child.
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00351234 -
Carnitine Levels and Carnitine Supplementation in Type I Diabetes
|
N/A | |
Recruiting |
NCT00875290 -
The Effectiveness of Continuous Glucose Monitoring in Diabetes Treatment for Infants and Young Children
|
Phase 3 | |
Completed |
NCT00888628 -
Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients
|
Phase 1/Phase 2 | |
Completed |
NCT00147342 -
The Effect of Insulin During Exercise on the Development of Low Blood Sugar in Individuals With Type I Diabetes
|
N/A | |
Completed |
NCT00118976 -
Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease
|
N/A | |
Active, not recruiting |
NCT02081326 -
Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes
|
Phase 2 | |
Completed |
NCT00109434 -
Study to Determine the Relationship Between Exercise and Hypoglycemia in Children With Type 1 Diabetes
|
N/A | |
Withdrawn |
NCT00790439 -
Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant
|
Phase 2 | |
Completed |
NCT00789308 -
Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation
|
Phase 2 | |
Completed |
NCT02970357 -
Evaluation of the Impact of a Therapeutic Education Program for Children With Type 1 Diabetes
|
N/A | |
Completed |
NCT02521675 -
Validation of Algorithms for Basal Insulin Rate Reductions in Type 1 Diabetic Patients Practising Physical Activity in Real Life Conditions
|
N/A | |
Completed |
NCT01781975 -
Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus
|
Phase 2 | |
Completed |
NCT00368394 -
Dose-Exposure-Response in Type 1 Diabetes Mellitus
|
Phase 1 | |
Terminated |
NCT04591925 -
SteadiSetâ„¢ Pilot Study (SteP Study)
|
N/A | |
Not yet recruiting |
NCT06147583 -
Assessing Detection Algorithms for Insulin Pump Malfunctions in Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT00306098 -
Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression
|
Phase 2 | |
Recruiting |
NCT05708820 -
Online Education Programme for People With Type 1 Diabetes and Suboptimal Metabolic Control
|
N/A | |
Completed |
NCT02556554 -
Pilot Prospective CGM Quality Improvement (QI) Project in Pregnancy
|
N/A | |
Completed |
NCT00652288 -
Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs
|
Phase 1 |